All Stories

  1. SISPA-Seq for rapid whole genome surveys of bacterial isolates

    Article • Infection Genetics and Evolution, June 2015, Elsevier

    Dr Michael R Jacobs

  2. Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases

    Article • Diagnostic Microbiology and Infectious Disease, May 2015, Elsevier

    Dr Michael R Jacobs, Wright Nichols

  3. First Report of an OXA-48-Producing Multidrug-Resistant Proteus mirabilis Strain from Gaza, Palestine

    Article • Antimicrobial Agents and Chemotherapy, April 2015, ASM Journals

    Dr Michael R Jacobs

  4. Multicenter Evaluation of Candida QuickFISH BC for Identification of Candida Species Directly from Blood Culture Bottles

    Article • Journal of Clinical Microbiology, March 2015, ASM Journals

    Dr Michael R Jacobs

  5. Complete Sequence of ablaKPC-Harboring Cointegrate Plasmid Isolated from Escherichia coli

    Article • Antimicrobial Agents and Chemotherapy, March 2015, ASM Journals

    Dr Michael R Jacobs

  6. Fulminant endocarditis and disseminated infection caused by carbapenem-resistantAcinetobacter baumanniiin a renal-pancreas transplant recipient

    Article • Transplant Infectious Disease, February 2015, Wiley

    Dr Michael R Jacobs

  7. Genomic and Transcriptomic Analyses of Colistin-Resistant Clinical Isolates of Klebsiella pneumoniae Reveal Multiple Pathways of Resistance

    Article • Antimicrobial Agents and Chemotherapy, November 2014, ASM Journals

    Dr Michael R Jacobs, David van Duin

  8. Erratum for Wright et al., Population Structure of KPC-Producing Klebsiella pneumoniae Isolates from Midwestern U.S. Hospitals

    Article • Antimicrobial Agents and Chemotherapy, September 2014, ASM Journals

    Dr Michael R Jacobs, David van Duin

  9. Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine

    Article • Diagnostic Microbiology and Infectious Disease, September 2014, Elsevier

    Dr Michael R Jacobs

  10. Extensively Drug-Resistant Pseudomonas aeruginosa Isolates ContainingblaVIM-2and Elements of Salmonella Genomic Island 2: a New Genetic Resistance Determinant in Northeast Ohio

    Article • Antimicrobial Agents and Chemotherapy, July 2014, ASM Journals

    Dr Michael R Jacobs

  11. Identification of Occult Fusobacterium nucleatum Central Nervous System Infection by Use of PCR-Electrospray Ionization Mass Spectrometry

    Article • Journal of Clinical Microbiology, June 2014, ASM Journals

    Dr Michael R Jacobs

  12. Population Structure of KPC-Producing Klebsiella pneumoniae Isolates from Midwestern U.S. Hospitals

    Article • Antimicrobial Agents and Chemotherapy, June 2014, ASM Journals

    Dr Michael R Jacobs, David van Duin

  13. Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network

    Article • Antimicrobial Agents and Chemotherapy, May 2014, ASM Journals

    David van Duin, Dr Michael R Jacobs

  14. Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae

    Article • Proceedings of the National Academy of Sciences, March 2014, Proceedings of the National Academy of Sciences

    Dr Michael R Jacobs

  15. Comparative Genomic Analysis of KPC-Encoding pKpQIL-Like Plasmids and Their Distribution in New Jersey and New York Hospitals

    Article • Antimicrobial Agents and Chemotherapy, March 2014, ASM Journals

    Dr Roberto G Melano, Dr Michael R Jacobs

  16. Molecular Survey of the Dissemination of TwoblaKPC-Harboring IncFIA Plasmids in New Jersey and New York Hospitals

    Article • Antimicrobial Agents and Chemotherapy, February 2014, ASM Journals

    Dr Roberto G Melano, Dr Michael R Jacobs

  17. New Insights into Dissemination and Variation of the Health Care-Associated Pathogen Acinetobacter baumannii from Genomic Analysis

    Article • mBio, January 2014, ASM Journals

    Dr Michael R Jacobs

  18. Complete Sequence of a KPC-Producing IncN Multidrug-Resistant Plasmid from an Epidemic Escherichia coli Sequence Type 131 Strain in China

    Article • Antimicrobial Agents and Chemotherapy, January 2014, ASM Journals

    Dr Michael R Jacobs

  19. Complete Nucleotide Sequence of ablaKPC-Harboring IncI2 Plasmid and Its Dissemination in New Jersey and New York Hospitals

    Article • Antimicrobial Agents and Chemotherapy, July 2013, ASM Journals

    Dr Roberto G Melano, Dr Michael R Jacobs

  20. Antimicrobial-resistantStreptococcus pneumoniae: trends and management

    Article • April 2013, Future Medicine

    Dr Michael R Jacobs

  21. The Potential of Human Nasal Colonization withStreptococcus pneumoniaeas a Universal Pneumococcal Vaccine

    Article • American Journal of Respiratory and Critical Care Medicine, April 2013, American Thoracic Society

    Dr Michael R Jacobs

  22. Complete Sequence of ablaKPC-2-Harboring IncFIIK1Plasmid from a Klebsiella pneumoniae Sequence Type 258 Strain

    Article • Antimicrobial Agents and Chemotherapy, January 2013, ASM Journals

    Dr Roberto G Melano, Dr Michael R Jacobs

  23. Complete Nucleotide Sequences ofblaKPC-4- andblaKPC-5-Harboring IncN and IncX Plasmids from Klebsiella pneumoniae Strains Isolated in New Jersey

    Article • Antimicrobial Agents and Chemotherapy, October 2012, ASM Journals

    Dr Roberto G Melano, Dr Michael R Jacobs

  24. Longitudinal Analysis of the Temporal Evolution of Acinetobacter baumannii Strains in Ohio, USA, by Using Rapid Automated Typing Methods

    Article • PLoS ONE, April 2012, PLOS

    Dr Michael R Jacobs

  25. "Silent" Dissemination of Klebsiella pneumoniae Isolates Bearing K. pneumoniae Carbapenemase in a Long-term Care Facility for Children and Young Adults in Northeast Ohio

    Article • Clinical Infectious Diseases, April 2012, Oxford University Press (OUP)

    Dr Michael R Jacobs

  26. Pneumonia Due to Drug-Resistant Streptococcus pneumoniae

    Article • Current Infectious Disease Reports, April 2012, Springer Science + Business Media

    Dr Michael R Jacobs

  27. Partial Excision ofblaKPCfrom Tn4401in Carbapenem-Resistant Klebsiella pneumoniae

    Article • Antimicrobial Agents and Chemotherapy, December 2011, ASM Journals

    Dr Michael R Jacobs

  28. Antimicrobial Activity of B-Lock against Bacterial and Candida spp. Causing Catheter-Related Bloodstream Infections

    Article • Antimicrobial Agents and Chemotherapy, July 2011, ASM Journals

    Dr Michael R Jacobs

  29. Are We Ready for Novel Detection Methods to Treat Respiratory Pathogens in Hospital-Acquired Pneumonia?

    Article • Clinical Infectious Diseases, April 2011, Oxford University Press (OUP)

    Dr Michael R Jacobs

  30. In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii

    Article • Journal of Antimicrobial Chemotherapy, February 2011, Oxford University Press (OUP)

    Dr Michael R Jacobs

  31. Emergence of Linezolid-ResistantStaphylococcus aureusafter Prolonged Treatment of Cystic Fibrosis Patients in Cleveland, Ohio

    Article • Antimicrobial Agents and Chemotherapy, January 2011, ASM Journals

    Dr Michael R Jacobs

  32. Novel bis-indole agents active against multidrug-resistant Acinetobacter baumannii

    Article • Diagnostic Microbiology and Infectious Disease, January 2011, Elsevier

    Dr Michael R Jacobs

  33. Use of Vaporized Hydrogen Peroxide Decontamination during an Outbreak of Multidrug-Resistant Acinetobacter baumannii Infection at a Long-Term Acute Care Hospital

    Article • Infection Control and Hospital Epidemiology, December 2010, Cambridge University Press

    Dr Michael R Jacobs

  34. Evaluation of Updated Interpretative Criteria for CategorizingKlebsiella pneumoniaewith Reduced Carbapenem Susceptibility

    Article • Journal of Clinical Microbiology, September 2010, ASM Journals

    Dr Michael R Jacobs

  35. Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia

    Article • International Journal of Antimicrobial Agents, September 2010, Elsevier

    Dr Michael R Jacobs

  36. Comparison of transformation frequencies among selected Streptococcus pneumoniae serotypes

    Article • International Journal of Antimicrobial Agents, August 2010, Elsevier

    Dr Michael R Jacobs

  37. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination

    Article • Journal of Antimicrobial Chemotherapy, May 2010, Oxford University Press (OUP)

    Dr Michael R Jacobs

  38. Evaluation of a Commercial Microarray System for Detection of SHV-, TEM-, CTX-M-, and KPC-Type  -Lactamase Genes in Gram-Negative Isolates

    Article • Journal of Clinical Microbiology, May 2010, ASM Journals

    Dr Michael R Jacobs

  39. Serotypes And Antimicrobial Susceptibility Of Streptococcus Pneumoniae Isolates From FOCUS 1 And 2, Two International Trials Of Ceftaroline In Patients Hospitalized For Community-acquired Bacterial Pneumonia

    Article • May 2010, American Thoracic Society

    Dr Michael R Jacobs

  40. In Vitro Activity of Fosfomycin against blaKPC-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin

    Article • Antimicrobial Agents and Chemotherapy, November 2009, ASM Journals

    Dr Michael R Jacobs

  41. Molecular characterisation of meticillin-resistant Staphylococcus aureus isolates from two ceftobiprole Phase 3 complicated skin and skin-structure infection clinical trials

    Article • International Journal of Antimicrobial Agents, August 2009, Elsevier

    Dr. Karen Bush, Dr Michael R Jacobs

  42. Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System

    Article • Antimicrobial Agents and Chemotherapy, June 2009, ASM Journals

    Dr Michael R Jacobs

  43. Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA

    Article • Journal of Antimicrobial Chemotherapy, January 2009, Oxford University Press (OUP)

    Dr Michael R Jacobs

  44. Mechanisms of Resistance in Haemophilus influenzae and Moraxella catarrhalis

    Article • January 2009, Springer Science + Business Media

    Dr Michael R Jacobs

  45. Emergence of Streptococcus pneumoniae Serotypes 19A, 6C, and 22F and Serogroup 15 in Cleveland, Ohio, in Relation to Introduction of the Protein‐Conjugated Pneumococcal Vaccine

    Article • Clinical Infectious Diseases, December 2008, Oxford University Press (OUP)

    Dr Michael R Jacobs

  46. Occurrence, Distribution, and Origins of Streptococcus pneumoniae Serotype 6C, a Recently Recognized Serotype

    Article • Journal of Clinical Microbiology, October 2008, ASM Journals

    Dr Michael R Jacobs

  47. Antimicrobial-resistantStreptococcus pneumoniae: trends and management

    Article • Expert Review of Anti-infective Therapy, October 2008, Taylor & Francis

    Dr Michael R Jacobs

  48. Presence of Plasmid-Mediated Quinolone Resistance in Klebsiella pneumoniae Isolates Possessing blaKPC in the United States

    Article • Antimicrobial Agents and Chemotherapy, April 2008, ASM Journals

    Dr Michael R Jacobs

  49. Combating resistance: application of the emerging science of pharmacokinetics and pharmacodynamics

    Article • International Journal of Antimicrobial Agents, December 2007, Elsevier

    Dr Michael R Jacobs

  50. Antimicrobial Resistance in Haemophilus influenzae

    Article • Clinical Microbiology Reviews, April 2007, ASM Journals

    Dr Michael R Jacobs

  51. Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility

    Article • International Journal of Infectious Diseases, November 2006, Elsevier

    Dr Michael R Jacobs

  52. Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center

    Article • Antimicrobial Agents and Chemotherapy, September 2006, ASM Journals

    Dr Michael R Jacobs

  53. FAILURE OF A 5-DAY COURSE OF INTRAMUSCULAR CEFTRIAXONE TO ERADICATE STREPTOCOCCUS PNEUMONIAE FROM THE MIDDLE EAR

    Article • The Pediatric Infectious Disease Journal, February 2006, Wolters Kluwer Health

    Dr Michael R Jacobs

  54. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains

    Article • International Journal of Antimicrobial Agents, February 2005, Elsevier

    Dr Michael R Jacobs, Dr JAVIER GARAU

  55. Macrolide Resistance in Streptococcus pneumoniae: Clonality and Mechanisms of Resistance in 24 Countries

    Article • Current Drug Targets - Infectious Disorders, September 2004, Bentham Science Publishers

    Dr Klaudia Kosowska-Shick, Dr Michael R Jacobs

  56. Antianaerobic Activity of a Novel Fluoroquinolone, WCK 771, Compared to Those of Nine Other Agents

    Article • Antimicrobial Agents and Chemotherapy, August 2004, ASM Journals

    Dr Michael R Jacobs

  57. Streptococcus pneumoniae: Epidemiology and patterns of resistance

    Article • The American Journal of Medicine Supplements, August 2004, Elsevier

    Dr Michael R Jacobs

  58. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998–2001 U.S. Surveillance Study

    Article • Clinics in Laboratory Medicine, June 2004, Elsevier

    Dr Michael R Jacobs

  59. Antimicrobial Resistance: Challenges and Solutions

    Article • Clinics in Laboratory Medicine, June 2004, Elsevier

    Dr Michael R Jacobs

  60. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections

    Article • Clinics in Laboratory Medicine, June 2004, Elsevier

    Dr Michael R Jacobs

  61. Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns

    Article • Clinics in Laboratory Medicine, June 2004, Elsevier

    Dr Michael R Jacobs

  62. Antimicrobial Resistance: Challenges and Solutions

    Article • Clinics in Laboratory Medicine, June 2004, Elsevier

    Dr Michael R Jacobs

  63. Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000

    Article • International Journal of Antimicrobial Agents, April 2004, Elsevier

    Dr Michael R Jacobs

  64. Four Antibiotic‐Resistant Streptococcus pneumoniae Clones Unrelated to the Pneumococcal Conjugate Vaccine Serotypes, Including 2 New Serotypes, Causing Acute Otitis Media in Southern Israel

    Article • The Journal of Infectious Diseases, February 2004, Oxford University Press (OUP)

    Dr Michael R Jacobs

  65. Antimicrobial resistance among pediatric respiratory tract infections: clinical challenges

    Article • Seminars in Pediatric Infectious Diseases, January 2004, Elsevier

    Dr Michael R Jacobs

  66. Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 Gram-positive cocci

    Article • Journal of Antimicrobial Chemotherapy, September 2003, Oxford University Press (OUP)

    Dr Michael R Jacobs

  67. Postantibiotic Effects of Daptomycin against 14 Staphylococcal and Pneumococcal Clinical Isolates

    Article • Antimicrobial Agents and Chemotherapy, September 2003, ASM Journals

    Dr Michael R Jacobs

  68. Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children

    Article • The Pediatric Infectious Disease Journal, August 2003, Wolters Kluwer Health

    Dr Michael R Jacobs

  69. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents

    Article • Journal of Antimicrobial Chemotherapy, July 2003, Oxford University Press (OUP)

    Dr Michael R Jacobs, Prof Sergey Sidorenko

  70. Time-Kill Studies of the Antianaerobe Activity of Garenoxacin Compared with Those of Nine Other Agents

    Article • Antimicrobial Agents and Chemotherapy, April 2003, ASM Journals

    Dr Michael R Jacobs

  71. Cefotaxime-Resistant Bacteria Colonizing Older People Admitted to an Acute Care Hospital

    Article • Journal of the American Geriatrics Society, April 2003, Wiley

    Dr Michael R Jacobs

  72. Postantibiotic Effects of Garenoxacin (BMS-284756) against 12 Gram-Positive or -Negative Organisms

    Article • Antimicrobial Agents and Chemotherapy, March 2003, ASM Journals

    Dr Michael R Jacobs

  73. Effects of an Efflux Mechanism and Ribosomal Mutations on Macrolide Susceptibility of Haemophilus influenzae Clinical Isolates

    Article • Antimicrobial Agents and Chemotherapy, March 2003, ASM Journals

    Dr Michael R Jacobs

  74. Antianaerobe Activity of RBX 7644 (Ranbezolid), a New Oxazolidinone, Compared with Those of Eight Other Agents

    Article • Antimicrobial Agents and Chemotherapy, March 2003, ASM Journals

    Dr Michael R Jacobs

  75. Use of Appropriate Breakpoints in Antimicrobial Surveillance Studies

    Article • Clinical Infectious Diseases, December 2002, Oxford University Press (OUP)

    Dr Michael R Jacobs

  76. Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate

    Article • International Journal of Antimicrobial Agents, October 2002, Elsevier

    Dr Michael R Jacobs

  77. In Vivo Veritas: In Vitro Macrolide Resistance in Systemic Streptococcus pneumoniae Infections Does Result in Clinical Failure

    Article • Clinical Infectious Diseases, September 2002, Oxford University Press (OUP)

    Dr Michael R Jacobs

  78. Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin

    Article • International Journal of Antimicrobial Agents, August 2002, Elsevier

    Dr Michael R Jacobs

  79. Antimicrobial guidelines for the treatment of acute bacterial rhinosinusitis in immunocompetent children

    Article • International Journal of Pediatric Otorhinolaryngology, March 2002, Elsevier

    Dr Michael R Jacobs

  80. Antipneumococcal Activity of BMS 284756 Compared to Those of Six Other Agents

    Article • Antimicrobial Agents and Chemotherapy, January 2002, ASM Journals

    Dr Michael R Jacobs

  81. Antipneumococcal Activity of Ertapenem (MK-0826) Compared to Those of Other Agents

    Article • Antimicrobial Agents and Chemotherapy, January 2002, ASM Journals

    Dr Michael R Jacobs

  82. Comparative in vitro activity of gemifloxacin to other fluoroquinolones and non-quinolone agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1999–2000

    Article • International Journal of Antimicrobial Agents, January 2002, Elsevier

    Dr Michael R Jacobs

  83. Pneumococcal Conjugate Vaccine Serotypes of Streptococcus pneumoniae Isolates and the Antimicrobial Susceptibility of Such Isolates in Children with Otitis Media

    Article • Clinical Infectious Diseases, November 2001, Oxford University Press (OUP)

    Dr Michael R Jacobs

  84. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters

    Article • Clinical Microbiology and Infection, November 2001, Elsevier

    Dr Michael R Jacobs

  85. High prevalence of carriage of antibiotic-resistant Streptococcus pneumoniae in children in Kampala Uganda

    Article • International Journal of Antimicrobial Agents, May 2001, Elsevier

    Dr Michael R Jacobs

  86. Comparative Antianaerobic Activity of BMS 284756

    Article • Antimicrobial Agents and Chemotherapy, February 2001, ASM Journals

    Dr Michael R Jacobs

  87. Assumed versus Approved Breakpoints

    Article • Antimicrobial Agents and Chemotherapy, November 2000, ASM Journals

    Dr Michael R Jacobs

  88. Mediterranean clone of penicillin-susceptible, multidrug-resistant serotype 6B Streptococcus pneumoniae in Greece, Italy and Israel

    Article • International Journal of Antimicrobial Agents, November 2000, Elsevier

    Dr Michael R Jacobs

  89. Establishing Criteria for Assessment of Efficacy of Antimicrobial Agents in Acute Otitis Media

    Article • Antimicrobial Agents and Chemotherapy, September 2000, ASM Journals

    Dr Michael R Jacobs

  90. Susceptibility of 1100 Streptococcus pneumoniae strains isolated in 1997 from seven Latin American and Caribbean countries

    Article • International Journal of Antimicrobial Agents, September 2000, Elsevier

    Dr Michael R Jacobs

  91. Activity of gemifloxacin, a new broad-spectrum quinolone, against 200 pneumococci by four different susceptibility testing methods

    Article • Journal of Antimicrobial Chemotherapy, April 2000, Oxford University Press (OUP)

    Dr Michael R Jacobs

  92. Enterobacter Species Bacteremia: Factors Predictive of Mortality at a Tertiary Care Institution

    Article • Infectious Diseases in Clinical Practice, March 2000, Wolters Kluwer Health

    Dr Michael R Jacobs

  93. Serotypes and antimicrobial susceptibility in clinical isolates of Haemophilus influenzae from Korean children in prevaccination era

    Article • Journal of Korean Medical Science, January 2000, Korean Academy of Medical Sciences (KAMJE)

    Dr Michael R Jacobs

  94. Prevalence of mefE, erm and tet(M) genes in Streptococcus pneumoniae strains from central Italy

    Article • International Journal of Antimicrobial Agents, September 1999, Elsevier

    Dr Michael R Jacobs

  95. Spread of Drug‐Resistant Streptococcus pneumoniae in Asian Countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study

    Article • Clinical Infectious Diseases, June 1999, Oxford University Press (OUP)

    Dr Michael R Jacobs

  96. Drug-resistant Streptococcus pneumoniae: rational antibiotic choices

    Article • The American Journal of Medicine, May 1999, Elsevier

    Dr Michael R Jacobs

  97. Molecular epidemiological survey of penicillin-resistant Streptococcus pneumoniae from Asia, Europe, and North America

    Article • Diagnostic Microbiology and Infectious Disease, May 1999, Elsevier

    Dr Michael R Jacobs

  98. Streptococcus pneumoniae: Activity of newer agents against penicillin-resistant strains

    Article • Current Infectious Disease Reports, February 1999, Springer Science + Business Media

    Dr Michael R Jacobs

  99. Genetic Analysis of Serotype 23F Streptococcus pneumoniae Isolates from Several Countries by Penicillin-Binding Protein Gene Fingerprinting and Pulsed-Field Gel Electrophoresis

    Article • Chemotherapy, January 1999, Karger Publishers

    Dr Michael R Jacobs

  100. Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group

    Article • The Pediatric Infectious Disease Journal, January 1999, Wolters Kluwer Health

    Dr Michael R Jacobs

  101. Antimicrobial susceptibility of Streptococcus pneumoniae from children attending day-care lefts in a central Italian city

    Article • Clinical Microbiology and Infection, November 1998, Elsevier

    Dr Michael R Jacobs

  102. Antibiotic-resistant Streptococcus pneumoniae in acute otitis media: overview and update

    Article • The Pediatric Infectious Disease Journal, October 1998, Wolters Kluwer Health

    Dr Michael R Jacobs

  103. Norwegian Scabies and a Toxic Shock Syndrome Toxin 1–Producing Strain of Staphylococcus aureus Endocarditis in a Patient with Trisomy 21

    Article • Clinical Infectious Diseases, September 1998, Oxford University Press (OUP)

    Dr Michael R Jacobs

  104. Spread of Multidrug‐Resistant Streptococcus pneumoniae in South Korea

    Article • Clinical Infectious Diseases, September 1997, Oxford University Press (OUP)

    Dr Michael R Jacobs

  105. Resistance Patterns of Streptococcus pneumoniae from Carriers Attending Day‐Care Centers in Southwestern Greece

    Article • Clinical Infectious Diseases, August 1997, Oxford University Press (OUP)

    Dr Michael R Jacobs

  106. Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media

    Article • The Pediatric Infectious Disease Journal, October 1996, Wolters Kluwer Health

    Dr Michael R Jacobs

  107. Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility

    Article • The Pediatric Infectious Disease Journal, October 1996, Wolters Kluwer Health

    Dr Michael R Jacobs

  108. Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: empiric therapy for febrile, neutropenic bone marrow transplant patients

    Article • International Journal of Antimicrobial Agents, July 1996, Elsevier

    Dr Michael R Jacobs

  109. Comparison of the activity of fluoroquinolones against Mycobacterium avium in cell-free systems and a human monocyte in-vitro infection model

    Article • Journal of Antimicrobial Chemotherapy, January 1996, Oxford University Press (OUP)

    Dr Michael R Jacobs

  110. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci

    Article • Antimicrobial Agents and Chemotherapy, July 1995, ASM Journals

    Dr Michael R Jacobs

  111. Activity of CP 99, 219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepaloxacin against penicillin-susceptible and -resistant pneumococci

    Article • Journal of Antimicrobial Chemotherapy, January 1995, Oxford University Press (OUP)

    Dr Michael R Jacobs

  112. Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin.

    Article • Antimicrobial Agents and Chemotherapy, February 1994, ASM Journals

    Dr Michael R Jacobs

  113. Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin.

    Article • Antimicrobial Agents and Chemotherapy, February 1994, ASM Journals

    Dr Michael R Jacobs

  114. Anti-Mycobacterium avium Activity of Quinolones: In Vitro Activities

    Article • Antimicrobial Agents and Chemotherapy, December 1993, ASM Journals

    Dr Michael R Jacobs

  115. Anti-Mycobacterium avium activity of quinolones: in vitro activities.

    Article • Antimicrobial Agents and Chemotherapy, September 1993, ASM Journals

    Dr Michael R Jacobs

  116. Anti-Mycobacterium avium activity of quinolones: structure-activity relationship studies.

    Article • Antimicrobial Agents and Chemotherapy, September 1993, ASM Journals

    Dr Michael R Jacobs

  117. ABSENCE OF ANTIBIOTIC-RESISTANT STREPTOCOCCUS PNEUMONIAE PHARYNGEAL COLONIZATION IN CLEVELAND CHILDREN WITH SICKLE CELL DISEASE

    Article • The Pediatric Infectious Disease Journal, September 1993, Wolters Kluwer Health

    Dr Michael R Jacobs

  118. Antimicrobial activity and in vitro corneal epithelial toxicity of antimicrobial agents for Gram-positive corneal pathogens

    Article • Current Eye Research, January 1993, Taylor & Francis

    Dr Michael R Jacobs

  119. Treatment and Diagnosis of Infections Caused by Drug-Resistant Streptococcus pneumoniae

    Article • Clinical Infectious Diseases, July 1992, Oxford University Press (OUP)

    Dr Michael R Jacobs

  120. Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.

    Article • Antimicrobial Agents and Chemotherapy, June 1991, ASM Journals

    Dr Michael R Jacobs

  121. Topical fluoroquinolones: Antimicrobial activity andin vitrocorneal epithelial toxicity

    Article • Current Eye Research, January 1991, Taylor & Francis

    Dr Michael R Jacobs

  122. Treatment of experimental Salmonella typhimurium infection in mice with fleroxacin.

    Article • Antimicrobial Agents and Chemotherapy, May 1988, ASM Journals

    Dr Michael R Jacobs

  123. In vitro activity of amiloride combined with tobramycin against Pseudomonas isolates from patients with cystic fibrosis.

    Article • Antimicrobial Agents and Chemotherapy, March 1988, ASM Journals

    Dr Michael R Jacobs

  124. In-vitro activity of erythromycin, roxithromycin and CP 62993 against common paediatric pathogens

    Article • Journal of Antimicrobial Chemotherapy, January 1987, Oxford University Press (OUP)

    Dr Michael R Jacobs

  125. Synergy of amoxycillin combined with clavulanate and YTR 830 in experimental infections in mice

    Article • Journal of Antimicrobial Chemotherapy, January 1986, Oxford University Press (OUP)

    Dr Michael R Jacobs

  126. Comparative activities of the β-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads

    Article • Journal of Antimicrobial Chemotherapy, January 1986, Oxford University Press (OUP)

    Dr Michael R Jacobs

  127. Infection caused by vancomycin-resistant Streptococcus sanguis II.

    Article • Antimicrobial Agents and Chemotherapy, April 1984, ASM Journals

    Dr Michael R Jacobs

  128. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis

    Article • Journal of Antimicrobial Chemotherapy, January 1983, Oxford University Press (OUP)

    Dr Michael R Jacobs

  129. Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.

    Article • Antimicrobial Agents and Chemotherapy, November 1982, ASM Journals

    Dr Michael R Jacobs

  130. Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection.

    Article • Antimicrobial Agents and Chemotherapy, August 1982, ASM Journals

    Dr Michael R Jacobs

  131. Penicillin susceptibility testing of gonococci by disc diffusion

    Article • Journal of Antimicrobial Chemotherapy, January 1981, Oxford University Press (OUP)

    Dr Michael R Jacobs

  132. Multiple-antibiotic resistance—now the pneumococcus

    Article • Journal of Antimicrobial Chemotherapy, January 1978, Oxford University Press (OUP)

    Dr Michael R Jacobs